A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
Health
'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
Get the latest trends and breaking news delivered to your inbox daily. No spam, just the good stuff.
Our content is free because of ads. Please support New Trend by disabling your ad blocker.
